A computational approach to unraveling TLR signaling in murine mammary carcinoma
暂无分享,去创建一个
Chun Wai Liew | Samantha Evans | Tiffany Phuong | Carli B. Jones | Justin Hoot | Kendall Weedling | Damarcus Ingram | Stacy Nganga | Robert A. Kurt | Samantha Evans | C. Liew | Damarcus Ingram | T. Phuong | R. Kurt | Justin Hoot | Kendall Weedling | Stacy Nganga
[1] H. Saji,et al. Significant correlation of monocyte chemoattractant protein‐1 expression with neovascularization and progression of breast carcinoma , 2001, Cancer.
[2] L. Hefler,et al. Monocyte Chemoattractant Protein-1 Serum Levels in Patients with Breast Cancer , 2004, Tumor Biology.
[3] Eric Bonabeau,et al. Agent-based modeling: Methods and techniques for simulating human systems , 2002, Proceedings of the National Academy of Sciences of the United States of America.
[4] R. Kurt,et al. Murine mammary carcinoma cells and CD11c(+) dendritic cells elicit distinct responses to lipopolysaccharide and exhibit differential expression of genes required for TLR4 signaling. , 2010, Cellular immunology.
[5] Yu-cai Fu,et al. Transcriptional regulation of increased CCL2 expression in pulmonary fibrosis involves nuclear factor-κB and activator protein-1. , 2013, The international journal of biochemistry & cell biology.
[6] E. D. Bal de Kier Joffé,et al. Dual activation of Toll-like receptors 7 and 9 impairs the efficacy of antitumor vaccines in murine models of metastatic breast cancer , 2017, Journal of Cancer Research and Clinical Oncology.
[7] Denis Thieffry,et al. Logical Modeling and Dynamical Analysis of Cellular Networks , 2016, Front. Genet..
[8] R. Ghosh,et al. To be an ally or an adversary in bladder cancer: the NF-κB story has not unfolded. , 2015, Carcinogenesis.
[9] William S. Hlavacek,et al. Rule-based Modeling and Simulation of Biochemical Systems with Molecular Finite , 2010 .
[10] H. Saji,et al. Significance of macrophage chemoattractant protein-1 in macrophage recruitment, angiogenesis, and survival in human breast cancer. , 2000, Clinical cancer research : an official journal of the American Association for Cancer Research.
[11] R. Lukaszewski,et al. Targeting the “Cytokine Storm” for Therapeutic Benefit , 2013, Clinical and Vaccine Immunology.
[12] E. Klipp,et al. Mathematical modeling of intracellular signaling pathways , 2006, BMC Neuroscience.
[13] F. Miller,et al. Selective events in the metastatic process defined by analysis of the sequential dissemination of subpopulations of a mouse mammary tumor. , 1992, Cancer research.
[14] T. S. P. S.,et al. GROWTH , 1924, Nature.
[15] Joseph D Butner,et al. Simulating cancer growth with multiscale agent-based modeling. , 2015, Seminars in cancer biology.
[16] C. Gilles,et al. EMT and inflammation: inseparable actors of cancer progression , 2017, Molecular oncology.
[17] Kumaresan Ganesan,et al. NFκB activation demarcates a subset of hepatocellular carcinoma patients for targeted therapy , 2016, Cellular Oncology.
[18] G. Schulert,et al. Macrophage activation syndrome and cytokine-directed therapies. , 2014, Best practice & research. Clinical rheumatology.
[19] S. Chalmers,et al. Growth, metastasis, and expression of CCL2 and CCL5 by murine mammary carcinomas are dependent upon Myd88. , 2012, Cellular immunology.
[20] P. Allavena,et al. Molecular pathways in cancer-related inflammation. , 2011, Biochemia medica.
[21] Bo Cheng,et al. Cellular mechanosensing of the biophysical microenvironment: A review of mathematical models of biophysical regulation of cell responses. , 2017, Physics of life reviews.
[22] Q. Hu,et al. Crosstalk between the HIF-1 and Toll-like receptor/nuclear factor-κB pathways in the oral squamous cell carcinoma microenvironment , 2016, Oncotarget.
[23] D. Bray,et al. Computer simulation of the phosphorylation cascade controlling bacterial chemotaxis. , 1993, Molecular biology of the cell.
[24] C. Figdor,et al. Toll-like receptor expression and function in human dendritic cell subsets: implications for dendritic cell-based anti-cancer immunotherapy , 2010, Cancer Immunology, Immunotherapy.
[25] H. Kohrt,et al. In situ vaccination for the treatment of cancer. , 2016, Immunotherapy.